您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
Biotinylated ROR1 His&Avi Tag Protein, Human/Cynomolgus/Rhesus macaque

Biotinylated ROR1 His&Avi Tag Protein, Human/Cynomolgus/Rhesus macaque

货号: UA010788
价格: 2450
规格: 25μg
介绍: -
其他: -
产品规格
  • 物种

    Human/Cynomolgus/Rhesus macaque
  • 抗原名称

    MCM2
  • 分子别名

    ROR1, NTRKR1
  • Accession

    Q01973-1
  • 表达序列

    Gln30-Glu403, with C-terminal His and Avi tag
  • 表达宿主

    HEK293
  • 分子量

    60-70kDa (Reducing)

  • 纯度

    >95% by SDS-PAGE
  • 内毒素含量

    <1EU/μg
  • 标记

    Biotin
  • 标签

    Human Fc Tag
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, pH7.4.
  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.
  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.
  • 文献引用

    1. María Josefina Quezada, Pablo Lopez-Bergami. (2023). The signaling pathways activated by ROR1 in cancer. Cell Signal. 104:110588.

  • 稀释度

背景介绍
  • Receptor tyrosine kinase-like orphan receptors (RORs) are monotopic membrane proteins belonging to the receptor tyrosine kinase (RTK) family. RTKs play a role in the control of most basic cellular processes, including cell proliferation, differentiation, migration and metabolism. ROR1 contains 1 FZ (frizzled) domain, 1 Ig-like C2-type (immunoglobulin-like) domain, 1 kringle domain, 1 protein kinase domain. ROR1 is highly expressed in a wide variety of hematological and solid cancers, but is low or absent in adult tissues. ROR1 could interact with casein kinase 1 epsilon (CK1ε) to activate phosphoinositide 3-kinase-mediated AKT phosphorylation and cAMP-response-element-binding protein (CREB). Studies have demonstrated that it plays an important role in oncogenesis by activating cell survival signaling events, particularly the non-canonical WNT signaling pathway. Antibody-based immunotherapies targeting ROR1 have been developed and evaluated in preclinical and clinical studies with promising outcomes.

  • 电泳JSON

    • 1μg (R: reducing condition, N: non-reducing condition).

  • ELISA

    • Immobilized Biotinylated ROR1 His&Avi Tag, Human/Cynomolgus/Rhesus macaque (Cat. No. UA010788) at 2 μg/mL on Streptavidin precoated (0.5μg/well) plate, can bind Anti-Human ROR1 Monoclonal Antibody(Zilovertamab) with EC50 of 2.98-3.79ng/ml.